Onconetix Inc ONCO 深 沪
等待开盘 08-10 09:30:00 美东时间
0.8916
-0.012
-1.34%
华盛通- 最 高1.009
- 今 开0.899
- 成交量 10.22万股
- 最 低 0.7887
- 昨 收 0.9037
- 总市值 0
- 52周最高 6.73
- 市盈率 静 --
- 换手率 Infinity.00%
- 52周最低 0.0911
- 委 比 -32.43%
- 总股本 --
- 历史最高 93.41
- 量 比 0.42
- 振 幅 24.38%
- 历史最低 0.0503
- 每 手 1
- 风险率 1.03%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Dow Falls Over 100 Points; Home Depot Posts Upbeat Earnings
US stocks fall, Dow Jones down 0.34% & NASDAQ down 0.41% in morning trading. Home Depot reports upbeat earnings, while materials stocks drop 1.8%.
05-19 22:06
UPDATED: Onconetix Announces 1-For-10 Reverse Stock Split, Effective May 21, 2026
Onconetix, Inc. (NASDAQ:ONCO) ("Onconetix" or the "Company"), a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for oncology, today announced
05-19 20:43
Market-Moving News for March 27th
U: 18% | Unity Software shares are trading higher after the company issued preliminary Q1 2026 revenue guidance that exceeded its earlier outlook AZN: 3% | AstraZeneca shares are trading higher after the
03-27 19:18
Is Onconetix Inc Gaining or Losing Market Support?
Onconetix Inc's (NYSE:ONCO) short interest as a percent of float has fallen 13....
02-14 01:00
福特别克正式入局增程式混动！
（来源：车联新生态） 在最新一期工信部申报图上，获取到了一组江铃福特旗下福特烈马新能源的新车申报图，新车将会提供纯电和增程两种动力。目前，福特官方已经发布了最新...
2025-07-18 09:05
Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel
Onconetix, Inc. received approval from the Nasdaq Hearings Panel to continue listing on Nasdaq, contingent on meeting the Periodic Filing and Bid Price Listing Rules by June 13 and June 30, 2025, respectively. The company has already achieved compliance with the Periodic Filing Listing Rule and completed a 1-for-85 reverse stock split on June 13, 2025. It expects to meet the Bid Price Listing Rule by June 27, 2025.
2025-06-16 12:22
Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders
Onconetix, Inc. 宣布其股东批准了1:85的反向股票分割，以符合纳斯达克的最低股价要求。此次分割将在6月13日生效，流通股数将从4440万股减少至约52万股。此外，公司专注于男性健康和肿瘤学领域的生物技术产品。
2025-06-11 15:30
Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq
Onconetix, Inc. received a delisting notice from Nasdaq due to failure to file the 10-Q quarterly report, adding to previous violations of the minimum bid price rule. The company has requested a hearing scheduled for May 27, 2025, and intends to promptly file the required reports to regain compliance.
2025-05-22 20:50
Why Onconetix (ONCO) Shares Are Down 27%
Onconetix shares are trading lower by 27% Friday afternoon. The company announced a 1-for-40 reverse stock split.
2024-09-21 03:28
